These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23756023)

  • 21. The biological actions of prostanoids in adipose tissue in physiological and pathophysiological conditions.
    Civelek E; Ozen G
    Prostaglandins Leukot Essent Fatty Acids; 2022 Nov; 186():102508. PubMed ID: 36270150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin E
    Bryson TD; Harding P
    Biochem Pharmacol; 2023 Nov; 217():115813. PubMed ID: 37722627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulation of Calpain Proteolytic Systems Underlies Degenerative Vascular Disorders.
    Miyazaki T; Miyazaki A
    J Atheroscler Thromb; 2018 Jan; 25(1):1-15. PubMed ID: 28819082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The PTGS2/COX2-PGE
    Martín-Vázquez E; Cobo-Vuilleumier N; López-Noriega L; Lorenzo PI; Gauthier BR
    Int J Biol Sci; 2023; 19(13):4157-4165. PubMed ID: 37705740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent insights into the role of prostanoids in atherosclerotic vascular disease.
    Reiss AB; Edelman SD
    Curr Vasc Pharmacol; 2006 Oct; 4(4):395-408. PubMed ID: 17073704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin signaling in ciliogenesis and development.
    Jin D; Zhong TP
    J Cell Physiol; 2022 Jun; 237(6):2632-2643. PubMed ID: 34927727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The harms and benefits of inflammatory and immune responses in vascular disease.
    Chamorro A; Hallenbeck J
    Stroke; 2006 Feb; 37(2):291-3. PubMed ID: 16410468
    [No Abstract]   [Full Text] [Related]  

  • 28. A2 adenosine receptors and vascular pathologies.
    Johnston-Cox HA; Koupenova M; Ravid K
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):870-8. PubMed ID: 22423039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Advancements in CD47 Signal Transduction Pathways Involved in Vascular Diseases.
    Dou M; Chen Y; Hu J; Ma D; Xing Y
    Biomed Res Int; 2020; 2020():4749135. PubMed ID: 32733941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifaceted roles of PGE2 in inflammation and cancer.
    Nakanishi M; Rosenberg DW
    Semin Immunopathol; 2013 Mar; 35(2):123-37. PubMed ID: 22996682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory mediators in vascular disease: identifying promising targets for intracranial aneurysm research.
    Sawyer DM; Amenta PS; Medel R; Dumont AS
    Mediators Inflamm; 2015; 2015():896283. PubMed ID: 25922566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PGE2 and the immune response. A central role for prostaglandin E2 in downregulating the inflammatory immune response.
    van der Pouw Kraan TC; van Lier RA; Aarden LA
    Mol Med Today; 1995 May; 1(2):61. PubMed ID: 17607896
    [No Abstract]   [Full Text] [Related]  

  • 33. Inflammation and Cardiovascular Cross Talk in Ischemic Vascular Diseases.
    Zauli G; Tisato V; Raffetto JD; Vaccarezza M
    Mediators Inflamm; 2017; 2017():3161968. PubMed ID: 28458468
    [No Abstract]   [Full Text] [Related]  

  • 34. Microparticles and inflammatory joint disease.
    Prati C; Racadot E; Wendling D
    Joint Bone Spine; 2010 Dec; 77(6):496-8. PubMed ID: 20851030
    [No Abstract]   [Full Text] [Related]  

  • 35. Prostaglandin E2: at the crossroads between stem cell development, inflammation and cancer.
    Logan CM; Giordano A; Puca A; Cassone M
    Cancer Biol Ther; 2007 Oct; 6(10):1517-20. PubMed ID: 17954983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Regulatory Role and Mechanism of Energy Metabolism in Vascular Diseases.
    Sun T; Yuan W; Wei Y; Liao D; Tuo Q
    Front Biosci (Landmark Ed); 2024 Jan; 29(1):26. PubMed ID: 38287818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory and Immune Mechanisms in Vascular Disease. Bethesda, Maryland, USA. February 19-20, 1998. Abstracts.
    J Vasc Surg; 1998 Jun; 27(6):1152-92. PubMed ID: 9687242
    [No Abstract]   [Full Text] [Related]  

  • 38. Prostaglandin E2-induced inflammation: Relevance of prostaglandin E receptors.
    Kawahara K; Hohjoh H; Inazumi T; Tsuchiya S; Sugimoto Y
    Biochim Biophys Acta; 2015 Apr; 1851(4):414-21. PubMed ID: 25038274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂.
    Norberg JK; Sells E; Chang HH; Alla SR; Zhang S; Meuillet EJ
    Pharm Pat Anal; 2013 Mar; 2(2):265-88. PubMed ID: 24237030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of prostaglandin E2 in macrophage polarization: Insights into atherosclerosis.
    Wang W; Liang M; Wang L; Bei W; Rong X; Xu J; Guo J
    Biochem Pharmacol; 2023 Jan; 207():115357. PubMed ID: 36455672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.